IMNM
Price
$23.99
Change
-$2.42 (-9.16%)
Updated
Feb 5, 04:59 PM (EDT)
Capitalization
2.91B
42 days until earnings call
Intraday BUY SELL Signals
NRIX
Price
$15.94
Change
-$0.61 (-3.69%)
Updated
Feb 5, 04:59 PM (EDT)
Capitalization
1.7B
68 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

IMNM vs NRIX

Header iconIMNM vs NRIX Comparison
Open Charts IMNM vs NRIXBanner chart's image
Immunome
Price$23.99
Change-$2.42 (-9.16%)
Volume$27.51K
Capitalization2.91B
Nurix Therapeutics
Price$15.94
Change-$0.61 (-3.69%)
Volume$23.55K
Capitalization1.7B
IMNM vs NRIX Comparison Chart in %
IMNM
Daily Signal:
Gain/Loss:
NRIX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
IMNM vs. NRIX commentary
Feb 06, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMNM is a Buy and NRIX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 06, 2026
Stock price -- (IMNM: $26.41 vs. NRIX: $16.55)
Brand notoriety: IMNM and NRIX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMNM: 70% vs. NRIX: 59%
Market capitalization -- IMNM: $2.91B vs. NRIX: $1.7B
IMNM [@Biotechnology] is valued at $2.91B. NRIX’s [@Biotechnology] market capitalization is $1.7B. The market cap for tickers in the [@Biotechnology] industry ranges from $119.38B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMNM’s FA Score shows that 0 FA rating(s) are green whileNRIX’s FA Score has 1 green FA rating(s).

  • IMNM’s FA Score: 0 green, 5 red.
  • NRIX’s FA Score: 1 green, 4 red.
According to our system of comparison, NRIX is a better buy in the long-term than IMNM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMNM’s TA Score shows that 4 TA indicator(s) are bullish while NRIX’s TA Score has 3 bullish TA indicator(s).

  • IMNM’s TA Score: 4 bullish, 4 bearish.
  • NRIX’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, IMNM is a better buy in the short-term than NRIX.

Price Growth

IMNM (@Biotechnology) experienced а +6.71% price change this week, while NRIX (@Biotechnology) price change was -7.39% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -5.81%. For the same industry, the average monthly price growth was -1.54%, and the average quarterly price growth was +30.06%.

Reported Earning Dates

IMNM is expected to report earnings on Mar 19, 2026.

NRIX is expected to report earnings on Apr 14, 2026.

Industries' Descriptions

@Biotechnology (-5.81% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMNM($2.91B) has a higher market cap than NRIX($1.7B). IMNM YTD gains are higher at: 22.952 vs. NRIX (-12.757). IMNM has higher annual earnings (EBITDA): -231.45M vs. NRIX (-248.7M). NRIX has more cash in the bank: 429M vs. IMNM (273M). IMNM has less debt than NRIX: IMNM (4.01M) vs NRIX (56.5M). NRIX has higher revenues than IMNM: NRIX (83.7M) vs IMNM (9.68M).
IMNMNRIXIMNM / NRIX
Capitalization2.91B1.7B171%
EBITDA-231.45M-248.7M93%
Gain YTD22.952-12.757-180%
P/E RatioN/AN/A-
Revenue9.68M83.7M12%
Total Cash273M429M64%
Total Debt4.01M56.5M7%
TECHNICAL ANALYSIS
Technical Analysis
IMNMNRIX
RSI
ODDS (%)
Bearish Trend 2 days ago
82%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
85%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 10 days ago
80%
Declines
ODDS (%)
Bearish Trend 24 days ago
86%
Bearish Trend 2 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
88%
Aroon
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
IMNM
Daily Signal:
Gain/Loss:
NRIX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JVMTX29.200.35
+1.21%
JHancock Disciplined Value Mid Cap R4
GHTRX17.92N/A
N/A
Goldman Sachs International T/M Eq R6
BRXUX18.66-0.03
-0.16%
MFS Blended Research Intl Eq R4
IRSIX13.79-0.13
-0.93%
Voya Russell Small Cap Index Port A
IAFLX18.33-0.22
-1.19%
F/m Investments Large Cap Focused Inst

IMNM and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMNM has been closely correlated with ERAS. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if IMNM jumps, then ERAS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMNM
1D Price
Change %
IMNM100%
-2.08%
ERAS - IMNM
73%
Closely correlated
+6.19%
ARWR - IMNM
72%
Closely correlated
-5.66%
TERN - IMNM
72%
Closely correlated
-6.39%
GLSI - IMNM
72%
Closely correlated
-3.62%
VTYX - IMNM
70%
Closely correlated
-0.29%
More

NRIX and

Correlation & Price change

A.I.dvisor indicates that over the last year, NRIX has been closely correlated with KYMR. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if NRIX jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NRIX
1D Price
Change %
NRIX100%
-1.43%
KYMR - NRIX
72%
Closely correlated
+0.62%
SYRE - NRIX
70%
Closely correlated
-3.66%
TRDA - NRIX
70%
Closely correlated
-8.23%
IMNM - NRIX
70%
Closely correlated
-2.08%
ERAS - NRIX
69%
Closely correlated
+6.19%
More